TMDX Q2 2020 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M-40.2% YoY

Gross Profit

$2M56.3% margin

Operating Income

-$8M-231.8% margin

Net Income

-$8M-250.6% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-55.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$631,000

Balance Sheet

Total Assets

$163M

Total Liabilities

$49M

Stockholders' Equity

$114M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$6M	-40.2%
Gross Profit	$2M	$3M	-42.7%
Operating Income	-$8M	-$8M	-2.0%
Net Income	-$8M	-$9M	+7.6%

Revenue Segments

Ocs Heart Product

$2M65%

Ocs Liver Product

$736,00022%

Ocs Lung Product

$435,00013%

Geographic Segments

UNITED STATES

$2M80%

Non Us And Uk

$596,00020%